💥You asked, we answered!💥 We’re expanding our portfolio of comprehensive genomic profiling (#CGP) solutions by launching a homologous recombination deficiency (#HRD) assessment. Available as a standalone assay, spiked-in as a supplementary module, or integrated in an Archer #NGS panel, the new #HRDmodule complements existing Archer microsatellite (#MSI) and tumor mutational burden (#TMB) modules to create a flexible, customizable CGP solution for labs looking to optimize sequencing resources. Read more here: https://idtb.io/6jn6cg
Integrated DNA Technologies
Biotechnology Research
Coralville, IA 78,720 followers
Lab to life-changing advances. We’ll help.
Über uns
For over 35 years, IDT has been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. IDT has evolved from a leading oligo manufacturer to a genomics solutions provider supporting areas such as NGS, CRISPR, SynBio, and PCR. With these core efforts, IDT teams have been helping to drive science forward with increased quality, efficiencies, and unmatched customer service. Today, technology is evolving faster than ever before. Scientists leading the transition from basic to translational research face new challenges with securing the solutions necessary to advance their research out of the lab and into the clinic. These emerging barriers have slowed down critical discoveries with potentially profound impacts on human and ecological health. To help overcome these obstacles and push the boundaries of technology, we've expanded production facilities and capabilities to include GMP and cGMP manufacturing grades. These additions provide customers with a genomics solutions partner capable of supporting the entire research journey. Combined with a renewed collaborative agility, members of our organization and strategic partners are positioned to contribute to the greatest genomic breakthroughs of our time. As we look to the future, our mission—accelerating the pace of genomics—honors our legacy and represents our commitment to the pursuit of new ideas to help us realize our shared vision of enabling researchers to rapidly move from the lab to life-changing advances. IDT is proud to be part of Danaher, a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. For more information, visit www.idtdna.com.
- Website
-
https://www.idtdna.com
External link for Integrated DNA Technologies
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 1.001-5.000 Mitarbeiter
- Hauptsitz
- Coralville, IA
- Typ
- In Privatbesitz
- Gegründet
- 1987
- Spezialitäten
- Custom Oligonucleotides, Next generation sequencing, Nucleic Acid Synthesis, Genes & gene fragments, DNA Synthesis, Synthetic Biology, RNA Synthesis, Synthesis Reagents, Primers, GMP Manufacturing, Genotyping, Probes, RNAi, qPCR, and CRISPR genome editing
Standorte
Employees at Integrated DNA Technologies
Aktualisierungen
-
Integrated DNA Technologies reposted this
Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency (HRD) assessment. Available as a standalone assay, spiked-in as a supplementary module or integrated in an Archer NGS panel, the new HRD module complements existing Archer microsatellite (MSI) and tumor mutational burden (TMB) assessment capabilities to create a flexible, customizable CGP solution for labs looking to optimize sequencing resources.
-
IDT has long been heavily involved in #communitywork both at home and around the world. 🌎 Read here about the importance of community work to Sarah Yeoman, Corporate Communications Manager at IDT: https://bit.ly/3TehDh0
-
🤩We are thrilled to be hosting the IDT Synthetic Biology Leadership Seminar in Boston! 🧬The event will focus on advances in synthetic biology and biological engineering for the development of novel therapies. 🥼Major themes explored include translational genomics, therapeutic protein engineering, diagnostics via nanotechnology, and biosensors and biocircuits. 👉Space is limited, so register here today: https://idtb.io/m5rlkj #IDTsynbio #syntheticbiology #synbio
-
If you are researching the latest outbreak of SARS-CoV-2, take a look at our #qPCR and #NGSsolutions to help accelerate your research. 🦠 Discover what’s possible here: https://idtb.io/dmip0u #COVID #COVID19 #COVID19research
-
🩸 September is #BloodCancerAwarenessMonth, a period dedicated to raising awareness about the more than 100 different types of #bloodcancer impacting lives worldwide. Our partner, Rob Baker, the Molecular Haematology Operational Manager at Health Services Laboratories in London, had this to say about the important work happening in these areas. 👇
-
Calling all cancer researchers! 🥼 #ECP is just around the corner, and we’re excited to meet you. Visit us at booth #121 to learn more about how our #cancerresearch solutions can help empower confident insights: https://lnkd.in/dai6p9R #ECP24 #ECP2024
-
2️⃣ probe types. 3️⃣ sizes. Up to 🔟 license-free dyes. Multiplex your way with IDT’s PrimeTime™ qPCR Probe Assays. Learn more and order here: https://idtb.io/matf5u #qPCR #probeassays #multiplexing #pcr
-
The regulatory landscape is constantly shifting—read this article by Robert Falcone, PhD, FTOPRA, FRAPS, Sr. Manager of Regulatory Affairs at IDT, to see how companies like IDT are helping #regulatorybodies shape that change: https://bit.ly/3yXUatp #regulatoryaffairs #regulatory